Interacciones de Lincomicina

Lincomicina (Lincocin), antibiótico, tiene 10 interacciones documentadas en las etiquetas de la FDA y las hojas informativas que indexamos. Graves: 2; moderadas: 8; leves: 0; casos en los que una etiqueta indica que no hay ninguna interacción significativa: 0. Cada entrada de abajo cita la frase que la respalda. Esta página del medicamento es un punto de partida, no un veredicto sobre su situación.

Interacciones según la etiqueta

Interacciones graves (2)

  • AlcoholAlcoholGrave

    The preservative benzyl alcohol has been associated with serious adverse events, including the "gasping syndrome", and death in pediatric patients. (etiqueta de Lincomicina, Advertencias)

  • ClindamicinaantibióticoGrave

    CONTRAINDICATIONS LINCOCIN is contraindicated in patients previously found to be hypersensitive to lincomycin or clindamycin. (etiqueta de Lincomicina, Contraindicaciones)

Interacciones moderadas (8)

  • Atracuriobloqueador neuromuscularModerada

    Drug Interactions Lincomycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents; therefore, it should be used with caution in patients receiving such agents. (etiqueta de Lincomicina, Interacciones medicamentosas)

  • Cisatracuriobloqueador neuromuscularModerada

    Drug Interactions Lincomycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents; therefore, it should be used with caution in patients receiving such agents. (etiqueta de Lincomicina, Interacciones medicamentosas)

  • Rocuroniobloqueador neuromuscularModerada

    Drug Interactions Lincomycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents; therefore, it should be used with caution in patients receiving such agents. (etiqueta de Lincomicina, Interacciones medicamentosas)

  • Suxametonio (succinilcolina)bloqueador neuromuscularModerada

    Drug Interactions Lincomycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents; therefore, it should be used with caution in patients receiving such agents. (etiqueta de Lincomicina, Interacciones medicamentosas)

  • Toxina botulínica tipo Abloqueador neuromuscularModerada

    Drug Interactions Lincomycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents; therefore, it should be used with caution in patients receiving such agents. (etiqueta de Lincomicina, Interacciones medicamentosas)

  • Toxina incobotulínica Abloqueador neuromuscularModerada

    Drug Interactions Lincomycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents; therefore, it should be used with caution in patients receiving such agents. (etiqueta de Lincomicina, Interacciones medicamentosas)

  • Toxina onabotulínica Abloqueador neuromuscularModerada

    Drug Interactions Lincomycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents; therefore, it should be used with caution in patients receiving such agents. (etiqueta de Lincomicina, Interacciones medicamentosas)

  • Vecuroniobloqueador neuromuscularModerada

    Drug Interactions Lincomycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents; therefore, it should be used with caution in patients receiving such agents. (etiqueta de Lincomicina, Interacciones medicamentosas)

Compruebe Lincomicina frente a todo lo que toma. Añada su lista completa; todos los pares se comprueban a la vez.

Abrir en el verificador

No es un consejo médico. La gravedad refleja la redacción de la etiqueta, no sus circunstancias. Una señal «grave» puede ser algo habitual bajo supervisión y una «leve» puede ser importante a dosis altas. Consulte a un farmacéutico.